PA
Pondahavakkam Arunodayan Priya
About Pondahavakkam Arunodayan Priya
Data last updated:
Pondahavakkam Arunodayan Priya is a Director at Hubra Pharmaceuticals Private Limited (since 2016), Director at 3G Surgical Industries Private Limited (since 2019) and Director at Mokksha Management Services Private Limited (since 2013). The companies operate in Pharma, Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹18.20 Cr; the largest is Hubra Pharmaceuticals Private Limited at ₹13.56 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Mar 2016 | 2016 | ₹13.56 Cr (FY 2024) | Active | |
| Director | 08 Jan 2019 | 2019 | ₹2.83 Cr (FY 2024) | Active | |
| Director | 17 Oct 2013 | 2013 | ₹1.81 Cr (FY 2024) | Active |
Board colleagues of Pondahavakkam Arunodayan Priya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pondavakkam Arunagirinathan Arunodhayan | 06686017 | Hubra Pharmaceuticals Private Limited , 3G Surgical Industries Private Limited and 1 more | Managing Director |
| Pondavakkam Vijaya Arunagirinathan | 01933631 | Hubra Pharmaceuticals Private Limited | Director |
| Pondavakkam Ananthakrishnan Karthick | 08323967 | 3G Surgical Industries Private Limited | Director |
| Pondavakkam Ayyappan Kokila | 08323968 | 3G Surgical Industries Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pondahavakkam Arunodayan Priya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pondahavakkam Arunodayan Priya
Pondahavakkam Arunodayan Priya currently holds 3 directorships: Hubra Pharmaceuticals Private Limited (Director, since 17 Mar 2016, revenue ₹13.56 Cr (FY 2024)); 3G Surgical Industries Private Limited (Director, since 08 Jan 2019, revenue ₹2.83 Cr (FY 2024)); Mokksha Management Services Private Limited (Director, since 17 Oct 2013, revenue ₹1.81 Cr (FY 2024)).
Pondahavakkam Arunodayan Priya was first appointed on 17 Oct 2013 as Director at Mokksha Management Services Private Limited. The most recent appointment on record is 08 Jan 2019 at 3G Surgical Industries Private Limited.
The 3 current companies of Pondahavakkam Arunodayan Priya that report revenue have a combined latest revenue of ₹18.20 Cr: Hubra Pharmaceuticals Private Limited ₹13.56 Cr (FY 2024); 3G Surgical Industries Private Limited ₹2.83 Cr (FY 2024); Mokksha Management Services Private Limited ₹1.81 Cr (FY 2024).
The current boards of Pondahavakkam Arunodayan Priya's companies include Pondavakkam Arunagirinathan Arunodhayan (Hubra Pharmaceuticals Private Limited), Pondavakkam Vijaya Arunagirinathan (Hubra Pharmaceuticals Private Limited), Pondavakkam Ananthakrishnan Karthick (3G Surgical Industries Private Limited), Pondavakkam Ayyappan Kokila (3G Surgical Industries Private Limited).